nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftriaxone—SLC15A2—multiple sclerosis	0.581	0.823	CbGaD
Ceftriaxone—ALB—multiple sclerosis	0.125	0.177	CbGaD
Ceftriaxone—SLC22A11—Methotrexate—multiple sclerosis	0.0465	0.331	CbGbCtD
Ceftriaxone—ALB—Prednisone—multiple sclerosis	0.032	0.228	CbGbCtD
Ceftriaxone—SLC22A8—Methotrexate—multiple sclerosis	0.027	0.193	CbGbCtD
Ceftriaxone—SLC22A6—Methotrexate—multiple sclerosis	0.0188	0.134	CbGbCtD
Ceftriaxone—ALB—Methotrexate—multiple sclerosis	0.016	0.114	CbGbCtD
Ceftriaxone—SLC15A1—Proton/oligonucleotide cotransporters—SLC15A2—multiple sclerosis	0.00488	0.291	CbGpPWpGaD
Ceftriaxone—GLUL—peripheral nervous system—multiple sclerosis	0.00268	0.233	CbGeAlD
Ceftriaxone—GLUL—brainstem—multiple sclerosis	0.000897	0.0779	CbGeAlD
Ceftriaxone—Ceftibuten—SLC15A2—multiple sclerosis	0.000889	0.137	CrCbGaD
Ceftriaxone—GLUL—retina—multiple sclerosis	0.000865	0.0752	CbGeAlD
Ceftriaxone—Cefazolin—PON1—multiple sclerosis	0.000832	0.129	CrCbGaD
Ceftriaxone—Cefepime—SLC15A2—multiple sclerosis	0.000732	0.113	CrCbGaD
Ceftriaxone—GLUL—Amino acid and derivative metabolism—SRM—multiple sclerosis	0.000693	0.0414	CbGpPWpGaD
Ceftriaxone—Cefuroxime—SLC15A2—multiple sclerosis	0.000663	0.102	CrCbGaD
Ceftriaxone—SLC15A1—Amino acid and oligopeptide SLC transporters—SLC15A2—multiple sclerosis	0.000658	0.0393	CbGpPWpGaD
Ceftriaxone—GLUL—medulla oblongata—multiple sclerosis	0.000625	0.0543	CbGeAlD
Ceftriaxone—Cefixime—SLC15A2—multiple sclerosis	0.000573	0.0885	CrCbGaD
Ceftriaxone—GLUL—midbrain—multiple sclerosis	0.000572	0.0497	CbGeAlD
Ceftriaxone—GLUL—spinal cord—multiple sclerosis	0.000558	0.0485	CbGeAlD
Ceftriaxone—GLUL—Neuronal System—KCNA3—multiple sclerosis	0.000553	0.033	CbGpPWpGaD
Ceftriaxone—Ceftazidime—SLC15A2—multiple sclerosis	0.000538	0.0832	CrCbGaD
Ceftriaxone—Cefdinir—SLC15A2—multiple sclerosis	0.000528	0.0816	CrCbGaD
Ceftriaxone—GLUL—TNF alpha Signaling Pathway—SELE—multiple sclerosis	0.000497	0.0297	CbGpPWpGaD
Ceftriaxone—GLUL—nervous system—multiple sclerosis	0.00047	0.0408	CbGeAlD
Ceftriaxone—GLUL—central nervous system—multiple sclerosis	0.000452	0.0393	CbGeAlD
Ceftriaxone—SLC15A2—retina—multiple sclerosis	0.000447	0.0389	CbGeAlD
Ceftriaxone—GLUL—cerebellum—multiple sclerosis	0.000442	0.0384	CbGeAlD
Ceftriaxone—GLUL—TNF alpha Signaling Pathway—TNFAIP3—multiple sclerosis	0.000437	0.0261	CbGpPWpGaD
Ceftriaxone—Cefotaxime—SLC15A2—multiple sclerosis	0.000414	0.064	CrCbGaD
Ceftriaxone—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC15A2—multiple sclerosis	0.000387	0.0231	CbGpPWpGaD
Ceftriaxone—GLUL—TNF alpha Signaling Pathway—TNFRSF1A—multiple sclerosis	0.000359	0.0214	CbGpPWpGaD
Ceftriaxone—GLUL—brain—multiple sclerosis	0.000359	0.0312	CbGeAlD
Ceftriaxone—Cefalotin—SLC15A2—multiple sclerosis	0.000357	0.0552	CrCbGaD
Ceftriaxone—SLC22A6—brain—multiple sclerosis	0.000357	0.031	CbGeAlD
Ceftriaxone—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.000337	0.0201	CbGpPWpGaD
Ceftriaxone—SLC15A2—medulla oblongata—multiple sclerosis	0.000323	0.0281	CbGeAlD
Ceftriaxone—SLC15A2—midbrain—multiple sclerosis	0.000295	0.0257	CbGeAlD
Ceftriaxone—SLC15A2—spinal cord—multiple sclerosis	0.000288	0.025	CbGeAlD
Ceftriaxone—SLC22A8—nervous system—multiple sclerosis	0.000279	0.0243	CbGeAlD
Ceftriaxone—SLC22A8—central nervous system—multiple sclerosis	0.000269	0.0234	CbGeAlD
Ceftriaxone—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.000257	0.0153	CbGpPWpGaD
Ceftriaxone—Cefotetan—ALB—multiple sclerosis	0.000252	0.039	CrCbGaD
Ceftriaxone—Sweating increased—Dexamethasone—multiple sclerosis	0.000243	0.00205	CcSEcCtD
Ceftriaxone—Sweating increased—Betamethasone—multiple sclerosis	0.000243	0.00205	CcSEcCtD
Ceftriaxone—SLC15A2—nervous system—multiple sclerosis	0.000243	0.0211	CbGeAlD
Ceftriaxone—Thrombophlebitis—Methotrexate—multiple sclerosis	0.000243	0.00205	CcSEcCtD
Ceftriaxone—Haemoglobin—Prednisolone—multiple sclerosis	0.000241	0.00203	CcSEcCtD
Ceftriaxone—Haemorrhage—Prednisolone—multiple sclerosis	0.000239	0.00202	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Mitoxantrone—multiple sclerosis	0.000236	0.00199	CcSEcCtD
Ceftriaxone—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.000235	0.014	CbGpPWpGaD
Ceftriaxone—Anaemia—Mitoxantrone—multiple sclerosis	0.000235	0.00198	CcSEcCtD
Ceftriaxone—SLC15A2—central nervous system—multiple sclerosis	0.000234	0.0203	CbGeAlD
Ceftriaxone—Hypersensitivity—Cladribine—multiple sclerosis	0.000232	0.00196	CcSEcCtD
Ceftriaxone—Epistaxis—Triamcinolone—multiple sclerosis	0.000231	0.00195	CcSEcCtD
Ceftriaxone—Malaise—Mitoxantrone—multiple sclerosis	0.000229	0.00193	CcSEcCtD
Ceftriaxone—SLC15A2—cerebellum—multiple sclerosis	0.000228	0.0199	CbGeAlD
Ceftriaxone—Leukopenia—Mitoxantrone—multiple sclerosis	0.000227	0.00192	CcSEcCtD
Ceftriaxone—Pruritus—Cladribine—multiple sclerosis	0.000223	0.00188	CcSEcCtD
Ceftriaxone—Dermatitis exfoliative—Methotrexate—multiple sclerosis	0.000223	0.00188	CcSEcCtD
Ceftriaxone—ALB—brain—multiple sclerosis	0.000222	0.0193	CbGeAlD
Ceftriaxone—Haemoglobin—Triamcinolone—multiple sclerosis	0.000221	0.00187	CcSEcCtD
Ceftriaxone—Haemoglobin—Methylprednisolone—multiple sclerosis	0.000221	0.00186	CcSEcCtD
Ceftriaxone—Haemorrhage—Triamcinolone—multiple sclerosis	0.00022	0.00186	CcSEcCtD
Ceftriaxone—Convulsion—Mitoxantrone—multiple sclerosis	0.00022	0.00186	CcSEcCtD
Ceftriaxone—Haemorrhage—Methylprednisolone—multiple sclerosis	0.00022	0.00185	CcSEcCtD
Ceftriaxone—Cefpiramide—ALB—multiple sclerosis	0.00022	0.0339	CrCbGaD
Ceftriaxone—Anaphylactoid reaction—Methotrexate—multiple sclerosis	0.000217	0.00183	CcSEcCtD
Ceftriaxone—Diarrhoea—Cladribine—multiple sclerosis	0.000216	0.00182	CcSEcCtD
Ceftriaxone—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC30A7—multiple sclerosis	0.000214	0.0128	CbGpPWpGaD
Ceftriaxone—Discomfort—Mitoxantrone—multiple sclerosis	0.000214	0.0018	CcSEcCtD
Ceftriaxone—SLC22A8—brain—multiple sclerosis	0.000214	0.0186	CbGeAlD
Ceftriaxone—Pancreatitis—Prednisone—multiple sclerosis	0.000213	0.0018	CcSEcCtD
Ceftriaxone—Sweating increased—Prednisone—multiple sclerosis	0.000212	0.00179	CcSEcCtD
Ceftriaxone—Feeling abnormal—Azathioprine—multiple sclerosis	0.000211	0.00178	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Azathioprine—multiple sclerosis	0.00021	0.00177	CcSEcCtD
Ceftriaxone—Dizziness—Cladribine—multiple sclerosis	0.000209	0.00176	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Mitoxantrone—multiple sclerosis	0.000207	0.00175	CcSEcCtD
Ceftriaxone—Oedema—Mitoxantrone—multiple sclerosis	0.000207	0.00175	CcSEcCtD
Ceftriaxone—Infection—Mitoxantrone—multiple sclerosis	0.000206	0.00174	CcSEcCtD
Ceftriaxone—Neutropenia—Prednisone—multiple sclerosis	0.000203	0.00171	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Mitoxantrone—multiple sclerosis	0.000203	0.00171	CcSEcCtD
Ceftriaxone—Abdominal pain—Azathioprine—multiple sclerosis	0.000203	0.00171	CcSEcCtD
Ceftriaxone—Body temperature increased—Azathioprine—multiple sclerosis	0.000203	0.00171	CcSEcCtD
Ceftriaxone—GLUL—Transmission across Chemical Synapses—BCHE—multiple sclerosis	0.000202	0.0121	CbGpPWpGaD
Ceftriaxone—SLC22A11—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000202	0.012	CbGpPWpGaD
Ceftriaxone—Haemoglobin—Dexamethasone—multiple sclerosis	0.000201	0.00169	CcSEcCtD
Ceftriaxone—Haemoglobin—Betamethasone—multiple sclerosis	0.000201	0.00169	CcSEcCtD
Ceftriaxone—Vomiting—Cladribine—multiple sclerosis	0.000201	0.00169	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.0002	0.00169	CcSEcCtD
Ceftriaxone—Haemorrhage—Betamethasone—multiple sclerosis	0.0002	0.00168	CcSEcCtD
Ceftriaxone—Haemorrhage—Dexamethasone—multiple sclerosis	0.0002	0.00168	CcSEcCtD
Ceftriaxone—Rash—Cladribine—multiple sclerosis	0.000199	0.00168	CcSEcCtD
Ceftriaxone—Dermatitis—Cladribine—multiple sclerosis	0.000199	0.00168	CcSEcCtD
Ceftriaxone—Ataxia—Methotrexate—multiple sclerosis	0.000198	0.00167	CcSEcCtD
Ceftriaxone—Headache—Cladribine—multiple sclerosis	0.000198	0.00167	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Prednisolone—multiple sclerosis	0.000193	0.00163	CcSEcCtD
Ceftriaxone—Cefonicid—ALB—multiple sclerosis	0.000191	0.0295	CrCbGaD
Ceftriaxone—GLUL—TNF alpha Signaling Pathway—CCL2—multiple sclerosis	0.00019	0.0114	CbGpPWpGaD
Ceftriaxone—Toxic epidermal necrolysis—Methotrexate—multiple sclerosis	0.000189	0.0016	CcSEcCtD
Ceftriaxone—Hypersensitivity—Azathioprine—multiple sclerosis	0.000189	0.00159	CcSEcCtD
Ceftriaxone—Malaise—Prednisolone—multiple sclerosis	0.000188	0.00158	CcSEcCtD
Ceftriaxone—Dysgeusia—Triamcinolone—multiple sclerosis	0.000188	0.00158	CcSEcCtD
Ceftriaxone—Nausea—Cladribine—multiple sclerosis	0.000187	0.00158	CcSEcCtD
Ceftriaxone—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000186	0.00157	CcSEcCtD
Ceftriaxone—SLC15A2—brain—multiple sclerosis	0.000186	0.0161	CbGeAlD
Ceftriaxone—Dyspepsia—Mitoxantrone—multiple sclerosis	0.000183	0.00154	CcSEcCtD
Ceftriaxone—Convulsion—Prednisolone—multiple sclerosis	0.000181	0.00152	CcSEcCtD
Ceftriaxone—Eosinophilia—Methotrexate—multiple sclerosis	0.00018	0.00152	CcSEcCtD
Ceftriaxone—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.000179	0.0107	CbGpPWpGaD
Ceftriaxone—Pancreatitis—Methotrexate—multiple sclerosis	0.000178	0.0015	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Triamcinolone—multiple sclerosis	0.000178	0.0015	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Methylprednisolone—multiple sclerosis	0.000177	0.0015	CcSEcCtD
Ceftriaxone—Pain—Mitoxantrone—multiple sclerosis	0.000177	0.00149	CcSEcCtD
Ceftriaxone—Diarrhoea—Azathioprine—multiple sclerosis	0.000175	0.00148	CcSEcCtD
Ceftriaxone—Discomfort—Prednisolone—multiple sclerosis	0.000175	0.00148	CcSEcCtD
Ceftriaxone—Haemoglobin—Prednisone—multiple sclerosis	0.000175	0.00147	CcSEcCtD
Ceftriaxone—Haemorrhage—Prednisone—multiple sclerosis	0.000174	0.00147	CcSEcCtD
Ceftriaxone—SLC15A1—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000173	0.0103	CbGpPWpGaD
Ceftriaxone—Malaise—Triamcinolone—multiple sclerosis	0.000173	0.00146	CcSEcCtD
Ceftriaxone—Malaise—Methylprednisolone—multiple sclerosis	0.000172	0.00145	CcSEcCtD
Ceftriaxone—Feeling abnormal—Mitoxantrone—multiple sclerosis	0.000171	0.00144	CcSEcCtD
Ceftriaxone—Oedema—Prednisolone—multiple sclerosis	0.00017	0.00143	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Prednisolone—multiple sclerosis	0.00017	0.00143	CcSEcCtD
Ceftriaxone—Neutropenia—Methotrexate—multiple sclerosis	0.00017	0.00143	CcSEcCtD
Ceftriaxone—Dizziness—Azathioprine—multiple sclerosis	0.00017	0.00143	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.00017	0.00143	CcSEcCtD
Ceftriaxone—Convulsion—Triamcinolone—multiple sclerosis	0.000166	0.0014	CcSEcCtD
Ceftriaxone—Convulsion—Methylprednisolone—multiple sclerosis	0.000166	0.0014	CcSEcCtD
Ceftriaxone—Urticaria—Mitoxantrone—multiple sclerosis	0.000165	0.00139	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000164	0.00139	CcSEcCtD
Ceftriaxone—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000164	0.00138	CcSEcCtD
Ceftriaxone—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000164	0.00138	CcSEcCtD
Ceftriaxone—Vomiting—Azathioprine—multiple sclerosis	0.000163	0.00137	CcSEcCtD
Ceftriaxone—Rash—Azathioprine—multiple sclerosis	0.000162	0.00136	CcSEcCtD
Ceftriaxone—Dermatitis—Azathioprine—multiple sclerosis	0.000162	0.00136	CcSEcCtD
Ceftriaxone—Flushing—Prednisone—multiple sclerosis	0.000161	0.00136	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Betamethasone—multiple sclerosis	0.000161	0.00136	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.000161	0.00136	CcSEcCtD
Ceftriaxone—Discomfort—Triamcinolone—multiple sclerosis	0.000161	0.00136	CcSEcCtD
Ceftriaxone—Discomfort—Methylprednisolone—multiple sclerosis	0.000161	0.00136	CcSEcCtD
Ceftriaxone—Headache—Azathioprine—multiple sclerosis	0.000161	0.00135	CcSEcCtD
Ceftriaxone—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000161	0.00135	CcSEcCtD
Ceftriaxone—ALB—HDL-mediated lipid transport—APOE—multiple sclerosis	0.000159	0.00951	CbGpPWpGaD
Ceftriaxone—Renal failure—Methotrexate—multiple sclerosis	0.000159	0.00134	CcSEcCtD
Ceftriaxone—Stomatitis—Methotrexate—multiple sclerosis	0.000158	0.00133	CcSEcCtD
Ceftriaxone—Malaise—Betamethasone—multiple sclerosis	0.000157	0.00132	CcSEcCtD
Ceftriaxone—Malaise—Dexamethasone—multiple sclerosis	0.000157	0.00132	CcSEcCtD
Ceftriaxone—Oedema—Triamcinolone—multiple sclerosis	0.000156	0.00132	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000156	0.00132	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000156	0.00132	CcSEcCtD
Ceftriaxone—Infection—Triamcinolone—multiple sclerosis	0.000155	0.00131	CcSEcCtD
Ceftriaxone—Infection—Methylprednisolone—multiple sclerosis	0.000155	0.00131	CcSEcCtD
Ceftriaxone—GLUL—Neuronal System—BCHE—multiple sclerosis	0.000155	0.00925	CbGpPWpGaD
Ceftriaxone—Haematuria—Methotrexate—multiple sclerosis	0.000154	0.0013	CcSEcCtD
Ceftriaxone—SLC22A8—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000154	0.00919	CbGpPWpGaD
Ceftriaxone—SLC22A11—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000153	0.00913	CbGpPWpGaD
Ceftriaxone—Epistaxis—Methotrexate—multiple sclerosis	0.000153	0.00129	CcSEcCtD
Ceftriaxone—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000153	0.00129	CcSEcCtD
Ceftriaxone—Paraesthesia—Prednisolone—multiple sclerosis	0.000153	0.00129	CcSEcCtD
Ceftriaxone—Nausea—Azathioprine—multiple sclerosis	0.000152	0.00128	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000151	0.00127	CcSEcCtD
Ceftriaxone—Agranulocytosis—Methotrexate—multiple sclerosis	0.000151	0.00127	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000151	0.00127	CcSEcCtD
Ceftriaxone—Convulsion—Dexamethasone—multiple sclerosis	0.000151	0.00127	CcSEcCtD
Ceftriaxone—Convulsion—Betamethasone—multiple sclerosis	0.000151	0.00127	CcSEcCtD
Ceftriaxone—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—multiple sclerosis	0.00015	0.00894	CbGpPWpGaD
Ceftriaxone—Discomfort—Betamethasone—multiple sclerosis	0.000146	0.00123	CcSEcCtD
Ceftriaxone—Discomfort—Dexamethasone—multiple sclerosis	0.000146	0.00123	CcSEcCtD
Ceftriaxone—Haemoglobin—Methotrexate—multiple sclerosis	0.000146	0.00123	CcSEcCtD
Ceftriaxone—Pain—Prednisolone—multiple sclerosis	0.000145	0.00123	CcSEcCtD
Ceftriaxone—Haemorrhage—Methotrexate—multiple sclerosis	0.000145	0.00123	CcSEcCtD
Ceftriaxone—Oedema—Betamethasone—multiple sclerosis	0.000142	0.0012	CcSEcCtD
Ceftriaxone—Oedema—Dexamethasone—multiple sclerosis	0.000142	0.0012	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000142	0.0012	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000142	0.0012	CcSEcCtD
Ceftriaxone—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000142	0.0012	CcSEcCtD
Ceftriaxone—SLC15A2—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000141	0.00843	CbGpPWpGaD
Ceftriaxone—Infection—Dexamethasone—multiple sclerosis	0.000141	0.00119	CcSEcCtD
Ceftriaxone—Infection—Betamethasone—multiple sclerosis	0.000141	0.00119	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Prednisone—multiple sclerosis	0.000141	0.00118	CcSEcCtD
Ceftriaxone—Paraesthesia—Triamcinolone—multiple sclerosis	0.00014	0.00118	CcSEcCtD
Ceftriaxone—Feeling abnormal—Prednisolone—multiple sclerosis	0.00014	0.00118	CcSEcCtD
Ceftriaxone—Paraesthesia—Methylprednisolone—multiple sclerosis	0.00014	0.00118	CcSEcCtD
Ceftriaxone—Anaemia—Prednisone—multiple sclerosis	0.00014	0.00118	CcSEcCtD
Ceftriaxone—Agitation—Prednisone—multiple sclerosis	0.000139	0.00117	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000139	0.00117	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000139	0.00117	CcSEcCtD
Ceftriaxone—Dyspepsia—Triamcinolone—multiple sclerosis	0.000138	0.00116	CcSEcCtD
Ceftriaxone—Erythema multiforme—Methotrexate—multiple sclerosis	0.000137	0.00116	CcSEcCtD
Ceftriaxone—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000137	0.00116	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000137	0.00116	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000137	0.00116	CcSEcCtD
Ceftriaxone—Malaise—Prednisone—multiple sclerosis	0.000137	0.00115	CcSEcCtD
Ceftriaxone—Urticaria—Prednisolone—multiple sclerosis	0.000135	0.00114	CcSEcCtD
Ceftriaxone—Pain—Triamcinolone—multiple sclerosis	0.000134	0.00113	CcSEcCtD
Ceftriaxone—Vomiting—Mitoxantrone—multiple sclerosis	0.000132	0.00111	CcSEcCtD
Ceftriaxone—Convulsion—Prednisone—multiple sclerosis	0.000131	0.00111	CcSEcCtD
Ceftriaxone—SLC15A1—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000131	0.00783	CbGpPWpGaD
Ceftriaxone—Rash—Mitoxantrone—multiple sclerosis	0.000131	0.0011	CcSEcCtD
Ceftriaxone—Dermatitis—Mitoxantrone—multiple sclerosis	0.000131	0.0011	CcSEcCtD
Ceftriaxone—Chills—Methotrexate—multiple sclerosis	0.00013	0.0011	CcSEcCtD
Ceftriaxone—ALB—Platelet degranulation—PLEK—multiple sclerosis	0.00013	0.00775	CbGpPWpGaD
Ceftriaxone—Headache—Mitoxantrone—multiple sclerosis	0.00013	0.0011	CcSEcCtD
Ceftriaxone—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000129	0.00109	CcSEcCtD
Ceftriaxone—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000129	0.00108	CcSEcCtD
Ceftriaxone—SLC22A6—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	0.000128	0.00767	CbGpPWpGaD
Ceftriaxone—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000128	0.00108	CcSEcCtD
Ceftriaxone—Paraesthesia—Dexamethasone—multiple sclerosis	0.000127	0.00107	CcSEcCtD
Ceftriaxone—Paraesthesia—Betamethasone—multiple sclerosis	0.000127	0.00107	CcSEcCtD
Ceftriaxone—Discomfort—Prednisone—multiple sclerosis	0.000127	0.00107	CcSEcCtD
Ceftriaxone—GLUL—Metabolism—SRM—multiple sclerosis	0.000127	0.0076	CbGpPWpGaD
Ceftriaxone—Hypersensitivity—Prednisolone—multiple sclerosis	0.000125	0.00106	CcSEcCtD
Ceftriaxone—Dyspepsia—Dexamethasone—multiple sclerosis	0.000125	0.00105	CcSEcCtD
Ceftriaxone—Dyspepsia—Betamethasone—multiple sclerosis	0.000125	0.00105	CcSEcCtD
Ceftriaxone—Urticaria—Triamcinolone—multiple sclerosis	0.000124	0.00105	CcSEcCtD
Ceftriaxone—Urticaria—Methylprednisolone—multiple sclerosis	0.000124	0.00105	CcSEcCtD
Ceftriaxone—Dysgeusia—Methotrexate—multiple sclerosis	0.000124	0.00105	CcSEcCtD
Ceftriaxone—ALB—Response to elevated platelet cytosolic Ca2+—PLEK—multiple sclerosis	0.000124	0.00739	CbGpPWpGaD
Ceftriaxone—Body temperature increased—Triamcinolone—multiple sclerosis	0.000124	0.00104	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Prednisone—multiple sclerosis	0.000124	0.00104	CcSEcCtD
Ceftriaxone—Oedema—Prednisone—multiple sclerosis	0.000124	0.00104	CcSEcCtD
Ceftriaxone—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000123	0.00104	CcSEcCtD
Ceftriaxone—Nausea—Mitoxantrone—multiple sclerosis	0.000123	0.00104	CcSEcCtD
Ceftriaxone—Infection—Prednisone—multiple sclerosis	0.000123	0.00104	CcSEcCtD
Ceftriaxone—Pain—Betamethasone—multiple sclerosis	0.000121	0.00102	CcSEcCtD
Ceftriaxone—Pain—Dexamethasone—multiple sclerosis	0.000121	0.00102	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Prednisone—multiple sclerosis	0.000119	0.00101	CcSEcCtD
Ceftriaxone—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000117	0.00099	CcSEcCtD
Ceftriaxone—Anaemia—Methotrexate—multiple sclerosis	0.000117	0.000986	CcSEcCtD
Ceftriaxone—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000117	0.000986	CcSEcCtD
Ceftriaxone—Feeling abnormal—Betamethasone—multiple sclerosis	0.000117	0.000986	CcSEcCtD
Ceftriaxone—SLC22A8—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	0.000117	0.00696	CbGpPWpGaD
Ceftriaxone—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000116	0.000979	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000116	0.000979	CcSEcCtD
Ceftriaxone—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000115	0.000972	CcSEcCtD
Ceftriaxone—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000115	0.00097	CcSEcCtD
Ceftriaxone—Malaise—Methotrexate—multiple sclerosis	0.000114	0.000962	CcSEcCtD
Ceftriaxone—Leukopenia—Methotrexate—multiple sclerosis	0.000113	0.000955	CcSEcCtD
Ceftriaxone—Urticaria—Dexamethasone—multiple sclerosis	0.000113	0.000951	CcSEcCtD
Ceftriaxone—Urticaria—Betamethasone—multiple sclerosis	0.000113	0.000951	CcSEcCtD
Ceftriaxone—Cefoperazone—ALB—multiple sclerosis	0.000113	0.0174	CrCbGaD
Ceftriaxone—Dizziness—Prednisolone—multiple sclerosis	0.000112	0.000948	CcSEcCtD
Ceftriaxone—Abdominal pain—Betamethasone—multiple sclerosis	0.000112	0.000946	CcSEcCtD
Ceftriaxone—Abdominal pain—Dexamethasone—multiple sclerosis	0.000112	0.000946	CcSEcCtD
Ceftriaxone—Body temperature increased—Dexamethasone—multiple sclerosis	0.000112	0.000946	CcSEcCtD
Ceftriaxone—Body temperature increased—Betamethasone—multiple sclerosis	0.000112	0.000946	CcSEcCtD
Ceftriaxone—Paraesthesia—Prednisone—multiple sclerosis	0.000111	0.000936	CcSEcCtD
Ceftriaxone—Pruritus—Triamcinolone—multiple sclerosis	0.000111	0.000933	CcSEcCtD
Ceftriaxone—Pruritus—Methylprednisolone—multiple sclerosis	0.00011	0.000931	CcSEcCtD
Ceftriaxone—GLUL—TNF alpha Signaling Pathway—MAPK1—multiple sclerosis	0.00011	0.00657	CbGpPWpGaD
Ceftriaxone—Convulsion—Methotrexate—multiple sclerosis	0.00011	0.000925	CcSEcCtD
Ceftriaxone—Dyspepsia—Prednisone—multiple sclerosis	0.000109	0.000917	CcSEcCtD
Ceftriaxone—Rash—Prednisolone—multiple sclerosis	0.000107	0.000904	CcSEcCtD
Ceftriaxone—Dermatitis—Prednisolone—multiple sclerosis	0.000107	0.000903	CcSEcCtD
Ceftriaxone—SLC22A11—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	0.000107	0.00638	CbGpPWpGaD
Ceftriaxone—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000107	0.0009	CcSEcCtD
Ceftriaxone—Headache—Prednisolone—multiple sclerosis	0.000107	0.000898	CcSEcCtD
Ceftriaxone—Discomfort—Methotrexate—multiple sclerosis	0.000106	0.000898	CcSEcCtD
Ceftriaxone—GLUL—TNF alpha Signaling Pathway—TNF—multiple sclerosis	0.000105	0.00625	CbGpPWpGaD
Ceftriaxone—Dizziness—Triamcinolone—multiple sclerosis	0.000103	0.000872	CcSEcCtD
Ceftriaxone—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000103	0.000871	CcSEcCtD
Ceftriaxone—Dizziness—Methylprednisolone—multiple sclerosis	0.000103	0.00087	CcSEcCtD
Ceftriaxone—Infection—Methotrexate—multiple sclerosis	0.000103	0.000865	CcSEcCtD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	0.000103	0.00612	CbGpPWpGaD
Ceftriaxone—Feeling abnormal—Prednisone—multiple sclerosis	0.000102	0.000859	CcSEcCtD
Ceftriaxone—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000101	0.000853	CcSEcCtD
Ceftriaxone—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000101	0.000852	CcSEcCtD
Ceftriaxone—Nausea—Prednisolone—multiple sclerosis	0.000101	0.000852	CcSEcCtD
Ceftriaxone—Pruritus—Dexamethasone—multiple sclerosis	0.0001	0.000847	CcSEcCtD
Ceftriaxone—Pruritus—Betamethasone—multiple sclerosis	0.0001	0.000847	CcSEcCtD
Ceftriaxone—Hyperhidrosis—Methotrexate—multiple sclerosis	9.99e-05	0.000842	CcSEcCtD
Ceftriaxone—Vomiting—Triamcinolone—multiple sclerosis	9.95e-05	0.000839	CcSEcCtD
Ceftriaxone—Vomiting—Methylprednisolone—multiple sclerosis	9.92e-05	0.000837	CcSEcCtD
Ceftriaxone—SLC15A2—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	9.88e-05	0.00589	CbGpPWpGaD
Ceftriaxone—Rash—Triamcinolone—multiple sclerosis	9.86e-05	0.000832	CcSEcCtD
Ceftriaxone—Dermatitis—Triamcinolone—multiple sclerosis	9.85e-05	0.000831	CcSEcCtD
Ceftriaxone—Rash—Methylprednisolone—multiple sclerosis	9.84e-05	0.00083	CcSEcCtD
Ceftriaxone—Dermatitis—Methylprednisolone—multiple sclerosis	9.83e-05	0.000829	CcSEcCtD
Ceftriaxone—Urticaria—Prednisone—multiple sclerosis	9.82e-05	0.000828	CcSEcCtD
Ceftriaxone—Headache—Triamcinolone—multiple sclerosis	9.8e-05	0.000826	CcSEcCtD
Ceftriaxone—Headache—Methylprednisolone—multiple sclerosis	9.78e-05	0.000824	CcSEcCtD
Ceftriaxone—Abdominal pain—Prednisone—multiple sclerosis	9.77e-05	0.000824	CcSEcCtD
Ceftriaxone—Body temperature increased—Prednisone—multiple sclerosis	9.77e-05	0.000824	CcSEcCtD
Ceftriaxone—SLC22A6—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	9.74e-05	0.00581	CbGpPWpGaD
Ceftriaxone—Diarrhoea—Dexamethasone—multiple sclerosis	9.71e-05	0.000819	CcSEcCtD
Ceftriaxone—Diarrhoea—Betamethasone—multiple sclerosis	9.71e-05	0.000819	CcSEcCtD
Ceftriaxone—Dizziness—Dexamethasone—multiple sclerosis	9.39e-05	0.000791	CcSEcCtD
Ceftriaxone—Dizziness—Betamethasone—multiple sclerosis	9.39e-05	0.000791	CcSEcCtD
Ceftriaxone—Nausea—Triamcinolone—multiple sclerosis	9.29e-05	0.000783	CcSEcCtD
Ceftriaxone—Paraesthesia—Methotrexate—multiple sclerosis	9.28e-05	0.000782	CcSEcCtD
Ceftriaxone—Nausea—Methylprednisolone—multiple sclerosis	9.27e-05	0.000782	CcSEcCtD
Ceftriaxone—Cefazolin—ALB—multiple sclerosis	9.26e-05	0.0143	CrCbGaD
Ceftriaxone—SLC15A1—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	9.17e-05	0.00547	CbGpPWpGaD
Ceftriaxone—ALB—Lipoprotein metabolism—APOE—multiple sclerosis	9.15e-05	0.00546	CbGpPWpGaD
Ceftriaxone—Hypersensitivity—Prednisone—multiple sclerosis	9.11e-05	0.000768	CcSEcCtD
Ceftriaxone—Dyspepsia—Methotrexate—multiple sclerosis	9.09e-05	0.000767	CcSEcCtD
Ceftriaxone—Vomiting—Dexamethasone—multiple sclerosis	9.02e-05	0.000761	CcSEcCtD
Ceftriaxone—Vomiting—Betamethasone—multiple sclerosis	9.02e-05	0.000761	CcSEcCtD
Ceftriaxone—GLUL—Metabolism—CYP27B1—multiple sclerosis	8.97e-05	0.00535	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—CYP24A1—multiple sclerosis	8.97e-05	0.00535	CbGpPWpGaD
Ceftriaxone—Rash—Dexamethasone—multiple sclerosis	8.95e-05	0.000755	CcSEcCtD
Ceftriaxone—Rash—Betamethasone—multiple sclerosis	8.95e-05	0.000755	CcSEcCtD
Ceftriaxone—Dermatitis—Dexamethasone—multiple sclerosis	8.94e-05	0.000754	CcSEcCtD
Ceftriaxone—Dermatitis—Betamethasone—multiple sclerosis	8.94e-05	0.000754	CcSEcCtD
Ceftriaxone—Headache—Dexamethasone—multiple sclerosis	8.89e-05	0.00075	CcSEcCtD
Ceftriaxone—Headache—Betamethasone—multiple sclerosis	8.89e-05	0.00075	CcSEcCtD
Ceftriaxone—Pain—Methotrexate—multiple sclerosis	8.83e-05	0.000745	CcSEcCtD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	8.8e-05	0.00525	CbGpPWpGaD
Ceftriaxone—Pruritus—Prednisone—multiple sclerosis	8.74e-05	0.000737	CcSEcCtD
Ceftriaxone—Feeling abnormal—Methotrexate—multiple sclerosis	8.51e-05	0.000718	CcSEcCtD
Ceftriaxone—Diarrhoea—Prednisone—multiple sclerosis	8.46e-05	0.000713	CcSEcCtD
Ceftriaxone—GLUL—TNF alpha Signaling Pathway—IL6—multiple sclerosis	8.46e-05	0.00505	CbGpPWpGaD
Ceftriaxone—Gastrointestinal pain—Methotrexate—multiple sclerosis	8.45e-05	0.000712	CcSEcCtD
Ceftriaxone—Nausea—Dexamethasone—multiple sclerosis	8.43e-05	0.000711	CcSEcCtD
Ceftriaxone—Nausea—Betamethasone—multiple sclerosis	8.43e-05	0.000711	CcSEcCtD
Ceftriaxone—Urticaria—Methotrexate—multiple sclerosis	8.21e-05	0.000692	CcSEcCtD
Ceftriaxone—GLUL—Metabolism—GPC5—multiple sclerosis	8.2e-05	0.0049	CbGpPWpGaD
Ceftriaxone—Dizziness—Prednisone—multiple sclerosis	8.17e-05	0.000689	CcSEcCtD
Ceftriaxone—Body temperature increased—Methotrexate—multiple sclerosis	8.17e-05	0.000689	CcSEcCtD
Ceftriaxone—Abdominal pain—Methotrexate—multiple sclerosis	8.17e-05	0.000689	CcSEcCtD
Ceftriaxone—SLC22A8—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	8.15e-05	0.00486	CbGpPWpGaD
Ceftriaxone—Vomiting—Prednisone—multiple sclerosis	7.86e-05	0.000663	CcSEcCtD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	7.82e-05	0.00467	CbGpPWpGaD
Ceftriaxone—Rash—Prednisone—multiple sclerosis	7.79e-05	0.000657	CcSEcCtD
Ceftriaxone—Dermatitis—Prednisone—multiple sclerosis	7.79e-05	0.000656	CcSEcCtD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	7.77e-05	0.00464	CbGpPWpGaD
Ceftriaxone—Headache—Prednisone—multiple sclerosis	7.74e-05	0.000653	CcSEcCtD
Ceftriaxone—Cefalotin—ALB—multiple sclerosis	7.69e-05	0.0119	CrCbGaD
Ceftriaxone—Hypersensitivity—Methotrexate—multiple sclerosis	7.61e-05	0.000642	CcSEcCtD
Ceftriaxone—Nausea—Prednisone—multiple sclerosis	7.34e-05	0.000619	CcSEcCtD
Ceftriaxone—Pruritus—Methotrexate—multiple sclerosis	7.31e-05	0.000616	CcSEcCtD
Ceftriaxone—ALB—Vitamin B12 Metabolism—CCL5—multiple sclerosis	7.3e-05	0.00436	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	7.18e-05	0.00429	CbGpPWpGaD
Ceftriaxone—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—multiple sclerosis	7.13e-05	0.00425	CbGpPWpGaD
Ceftriaxone—Diarrhoea—Methotrexate—multiple sclerosis	7.07e-05	0.000596	CcSEcCtD
Ceftriaxone—Dizziness—Methotrexate—multiple sclerosis	6.83e-05	0.000576	CcSEcCtD
Ceftriaxone—SLC22A6—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	6.8e-05	0.00406	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—RRM1—multiple sclerosis	6.8e-05	0.00406	CbGpPWpGaD
Ceftriaxone—ALB—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	6.68e-05	0.00399	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	6.67e-05	0.00398	CbGpPWpGaD
Ceftriaxone—Vomiting—Methotrexate—multiple sclerosis	6.57e-05	0.000554	CcSEcCtD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	6.53e-05	0.0039	CbGpPWpGaD
Ceftriaxone—Rash—Methotrexate—multiple sclerosis	6.51e-05	0.000549	CcSEcCtD
Ceftriaxone—Dermatitis—Methotrexate—multiple sclerosis	6.51e-05	0.000549	CcSEcCtD
Ceftriaxone—Headache—Methotrexate—multiple sclerosis	6.47e-05	0.000546	CcSEcCtD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—AQP4—multiple sclerosis	6.14e-05	0.00367	CbGpPWpGaD
Ceftriaxone—Nausea—Methotrexate—multiple sclerosis	6.14e-05	0.000517	CcSEcCtD
Ceftriaxone—ALB—Lipid and lipoprotein metabolism—APOE—multiple sclerosis	6.08e-05	0.00363	CbGpPWpGaD
Ceftriaxone—ALB—Vitamin B12 Metabolism—APOE—multiple sclerosis	5.98e-05	0.00357	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	5.93e-05	0.00354	CbGpPWpGaD
Ceftriaxone—GLUL—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	5.91e-05	0.00353	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—PLEK—multiple sclerosis	5.76e-05	0.00344	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—IL4—multiple sclerosis	5.76e-05	0.00344	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.68e-05	0.00339	CbGpPWpGaD
Ceftriaxone—ALB—Vitamin B12 Metabolism—ICAM1—multiple sclerosis	5.62e-05	0.00335	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	5.43e-05	0.00324	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	5.27e-05	0.00314	CbGpPWpGaD
Ceftriaxone—ALB—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	5.06e-05	0.00302	CbGpPWpGaD
Ceftriaxone—ALB—Vitamin B12 Metabolism—CCL2—multiple sclerosis	5.03e-05	0.003	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	5.02e-05	0.00299	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	4.95e-05	0.00295	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—CD58—multiple sclerosis	4.81e-05	0.00287	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—MERTK—multiple sclerosis	4.81e-05	0.00287	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—SELPLG—multiple sclerosis	4.81e-05	0.00287	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—AQP4—multiple sclerosis	4.69e-05	0.0028	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.66e-05	0.00278	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—ICAM1—multiple sclerosis	4.57e-05	0.00273	CbGpPWpGaD
Ceftriaxone—GLUL—Neuronal System—MAPK1—multiple sclerosis	4.53e-05	0.0027	CbGpPWpGaD
Ceftriaxone—ALB—Vitamin B12 Metabolism—IFNG—multiple sclerosis	4.28e-05	0.00255	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	4.14e-05	0.00247	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—CCL2—multiple sclerosis	4.09e-05	0.00244	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.91e-05	0.00233	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—BCHE—multiple sclerosis	3.9e-05	0.00233	CbGpPWpGaD
Ceftriaxone—SLC22A11—SLC-mediated transmembrane transport—ALB—multiple sclerosis	3.85e-05	0.0023	CbGpPWpGaD
Ceftriaxone—ALB—Vitamin B12 Metabolism—IL1B—multiple sclerosis	3.81e-05	0.00228	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—ICAM1—multiple sclerosis	3.63e-05	0.00217	CbGpPWpGaD
Ceftriaxone—SLC15A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	3.56e-05	0.00212	CbGpPWpGaD
Ceftriaxone—ALB—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	3.54e-05	0.00211	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—IFNG—multiple sclerosis	3.48e-05	0.00208	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	3.46e-05	0.00206	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	3.39e-05	0.00203	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	3.32e-05	0.00198	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	3.32e-05	0.00198	CbGpPWpGaD
Ceftriaxone—SLC15A1—SLC-mediated transmembrane transport—ALB—multiple sclerosis	3.3e-05	0.00197	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—CCL2—multiple sclerosis	3.25e-05	0.00194	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—IL1B—multiple sclerosis	3.1e-05	0.00185	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—IL2—multiple sclerosis	3.09e-05	0.00185	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—PLEK—multiple sclerosis	2.97e-05	0.00177	CbGpPWpGaD
Ceftriaxone—SLC22A8—SLC-mediated transmembrane transport—ALB—multiple sclerosis	2.94e-05	0.00175	CbGpPWpGaD
Ceftriaxone—ALB—Vitamin B12 Metabolism—TNF—multiple sclerosis	2.77e-05	0.00165	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—IFNG—multiple sclerosis	2.76e-05	0.00165	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	2.57e-05	0.00153	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—IL1B—multiple sclerosis	2.47e-05	0.00147	CbGpPWpGaD
Ceftriaxone—SLC22A6—SLC-mediated transmembrane transport—ALB—multiple sclerosis	2.45e-05	0.00146	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—APOE—multiple sclerosis	2.35e-05	0.0014	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—TNF—multiple sclerosis	2.25e-05	0.00134	CbGpPWpGaD
Ceftriaxone—ALB—Vitamin B12 Metabolism—IL6—multiple sclerosis	2.23e-05	0.00133	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—SRM—multiple sclerosis	2.1e-05	0.00125	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—SELE—multiple sclerosis	2.09e-05	0.00125	CbGpPWpGaD
Ceftriaxone—ALB—Platelet degranulation—TGFB1—multiple sclerosis	2.07e-05	0.00123	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—AQP4—multiple sclerosis	2.03e-05	0.00121	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—POMC—multiple sclerosis	2.02e-05	0.0012	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—IL2RA—multiple sclerosis	2.01e-05	0.0012	CbGpPWpGaD
Ceftriaxone—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—multiple sclerosis	1.97e-05	0.00118	CbGpPWpGaD
Ceftriaxone—SLC22A11—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.96e-05	0.00117	CbGpPWpGaD
Ceftriaxone—GLUL—Metabolism—ALB—multiple sclerosis	1.84e-05	0.0011	CbGpPWpGaD
Ceftriaxone—ALB—Folate Metabolism—IL6—multiple sclerosis	1.82e-05	0.00108	CbGpPWpGaD
Ceftriaxone—SLC15A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.81e-05	0.00108	CbGpPWpGaD
Ceftriaxone—ALB—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	1.8e-05	0.00107	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—TNF—multiple sclerosis	1.79e-05	0.00107	CbGpPWpGaD
Ceftriaxone—SLC15A1—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.68e-05	0.001	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—ITGA4—multiple sclerosis	1.51e-05	0.000903	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—IFNB1—multiple sclerosis	1.5e-05	0.000897	CbGpPWpGaD
Ceftriaxone—SLC22A8—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.49e-05	0.00089	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CYP27B1—multiple sclerosis	1.48e-05	0.000882	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—CYP24A1—multiple sclerosis	1.48e-05	0.000882	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	1.44e-05	0.000862	CbGpPWpGaD
Ceftriaxone—ALB—Selenium Micronutrient Network—IL6—multiple sclerosis	1.44e-05	0.000862	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—GPC5—multiple sclerosis	1.35e-05	0.000807	CbGpPWpGaD
Ceftriaxone—SLC22A6—Transmembrane transport of small molecules—ALB—multiple sclerosis	1.24e-05	0.000743	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—IL2—multiple sclerosis	1.18e-05	0.000702	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—RRM1—multiple sclerosis	1.12e-05	0.000668	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—IL2RA—multiple sclerosis	1.03e-05	0.000617	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—TGFB1—multiple sclerosis	9.17e-06	0.000547	CbGpPWpGaD
Ceftriaxone—ALB—Platelet activation, signaling and aggregation—MAPK1—multiple sclerosis	8.99e-06	0.000537	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	8.69e-06	0.000519	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	7.46e-06	0.000445	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—BCHE—multiple sclerosis	6.43e-06	0.000384	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—IL2—multiple sclerosis	6.06e-06	0.000362	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—TGFB1—multiple sclerosis	4.73e-06	0.000282	CbGpPWpGaD
Ceftriaxone—ALB—Hemostasis—MAPK1—multiple sclerosis	4.64e-06	0.000277	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—APOE—multiple sclerosis	3.87e-06	0.000231	CbGpPWpGaD
Ceftriaxone—ALB—Metabolism—POMC—multiple sclerosis	3.32e-06	0.000198	CbGpPWpGaD
